Follow up of BL/LL patients on a slightly modified WHO regimen of multidrug therapy.
No Thumbnail Available
Date
1987-01-01
Journal Title
Journal ISSN
Volume Title
Publisher
Abstract
56 lepromatous leprosy patients with an initial average BI of 4.45 were administered once a month 600 mg of Rifampicin, 100 mg of Clofazimine on alternate days and 100 mg of Dapsone daily. None of these patients became smear negative in 2 years, and the same regimen was continued further. Two patients have become negative in 3 years and treatment has been stopped in them. The study indicates that highly bacilliferous LL/BL patients are likely to need 3 years or more of MDT for achieving bacterial negativity.
Description
Keywords
Citation
Katoch K, Ramu G, Ramanathan U, Sengupta U, Sreevatsa . Follow up of BL/LL patients on a slightly modified WHO regimen of multidrug therapy. Indian Journal of Leprosy. 1987 Jan-Mar; 59(1): 36-43